Laura Wallenstein Named Philanthropy Officer for the Lymphoma Research Foundation
Twenty-year career fundraising expert to spearhead development initiatives for national blood cancer organization.
News
Frank Recruitment Group Partners with Lymphoma Research Foundation to Raise Awareness and Funds for Lymphoma
Frank Recruitment Group’s partnership will take place across all nine of their U.S.-based offices and the company will participate in LRF events and initiatives such as Lymphoma Walks, the Lymphoma Research Ride, Fundraise Your Way, Blood Cancer Awareness Month, and National Cancer Survivors Day.
CDC Updates COVID-19 Vaccine Guidance for Immunocompromised
On July 27, 2021, the Centers for Disease Control and Prevention (CDC) updated its Guidance for Fully Vaccinated people to include recommendations for those in the same household as immunocompromised people, including those with blood cancer.
Meet the 2021 Lymphoma Scientific Research Mentoring Program Scholars
The Lymphoma Scientific Research Mentoring Program (LSRMP) is a first-of-its-kind education and mentoring program for junior scientists who wish to focus on lymphoma clinical and laboratory/translational research.
Glass Half Full: A Story of Hope
At 24 years old, Nina Luker’s life was turned upside down when she learned she had stage IV diffuse large B-cell lymphoma (DLBCL) – just three days before New York City went on lockdown due to the 2020 COVID-19 Pandemic.…
Read the Latest Issue of Pulse: Summer 2021
Dear Friends of LRF, Every five minutes, someone in the U.S. is diagnosed with lymphoma. Yet, what brings me hope — and I hope you as well — is that advances in research have improved the way people are diagnosed…
Shining a Light on Lymphoma During Blood Cancer Awareness Month
Shinning a Light on Lymphoma During Blood Cancer Awareness Month Due in large part to the Lymphoma Research Foundation’s (LRF) Advocacy Program, the month of September was designated Blood Cancer Awareness Month (BCAM) by the U.S. Congress in 2010. Blood…
The Healing Power of Compassion
For Kami Maddocks, MD of the Ohio State University Comprehensive Cancer Center, the bonds she creates with her patients go far beyond the call of duty of a doctor and are the most rewarding aspect of her work.
Ride On! 15 Years of the Lymphoma Research Ride
In 2007, LRF Scientific Advisory Board member and past Chair, Dr. Bruce Cheson (Johns Hopkins Medicine/Center for Cancer and Blood Disorders) alongside his wife Christine, founded the Lymphoma Research Ride to give back to his patients, the medical community and raise funds to support life-saving research.
U.S. Food and Drug Administration Approves Belumosudil (REZUROCK) for Chronic Graft-Versus-Host Disease
Belumosudil (REZUROCK, Kadmon Pharmaceuticals, LLC), is a kinase inhibitor for chronic graft-versus-host disease (chronic GVHD) in adult and pediatric patients 12 years and older.